- Clinical Trials
- April 2024
- 120 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Phenazopyridine is a urological disorder drug used to treat urinary tract pain, burning, and discomfort. It is an analgesic and anesthetic agent that works by blocking the sensation of pain in the urinary tract. It is available in both over-the-counter and prescription forms. Phenazopyridine is often used to treat urinary tract infections, bladder infections, and other urological disorders. It is also used to relieve pain associated with kidney stones and other urinary tract conditions.
Phenazopyridine is available in various forms, including tablets, capsules, and liquids. It is also available in combination with other medications, such as antibiotics, to treat more severe urinary tract infections. The drug is generally well tolerated, with few side effects.
The Phenazopyridine market is highly competitive, with many companies offering various formulations of the drug. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more